• Our Partners
  • CarePolicy
  • HomeCareConsulting
  • Digit9X
  • Home
  • Assisted Living
  • Elderly
  • Home Care Agency
  • Home Care Worker
  • Home Nursing
Menu
  • Home
  • Assisted Living
  • Elderly
  • Home Care Agency
  • Home Care Worker
  • Home Nursing
Home » Abbott’s Apple Blood Glucose Monitoring System goes on sale in the U.S.
Assisted Living

Abbott’s Apple Blood Glucose Monitoring System goes on sale in the U.S.

adminBy adminSeptember 6, 2024No Comments3 Mins Read
Facebook Twitter Pinterest Telegram LinkedIn Tumblr Email Reddit
Share
Facebook Twitter LinkedIn Pinterest Email Copy Link


Global healthcare company Abbott has announced that its Lingo continuous glucose monitoring system is now available in the United States without a prescription.

Lingo includes a biosensor and mobile app based on Abbott’s FreeStyle Libre continuous glucose monitoring technology.

The system is a biowearable product intended for people aged 18 years or older who are not taking insulin.

It tracks blood glucose levels in real time and provides end-users with personal insights and guidance aimed at helping them build healthy habits, retrain their metabolism and improve their overall health.

“There is significant interest in tracking biomarkers that provide insights into an individual’s health and wellness that have not previously been detectable through consumer-available trackers,” Olivier Ropars, vice president of Abbott’s apple business, said in a statement.

“Blood glucose levels are powerful signals that show the body’s unique response to food and lifestyle. Abbott’s Lingo tracks blood glucose levels 24/7 and transforms that data into insights, bridging the gap between traditional healthcare and preventative measures. Lingo empowers individuals to develop new healthy habits and take control of their health and wellness.”

Larger trends

In August, Abbott introduced its Vertigo Coach app in India, where approximately 10 million people suffer from vertigo. The product is available on both Android and iOS devices, and the mobile app provides information and resources to help people suffering from vertigo manage their symptoms.

In 2022, Abbott’s implantable cardiac sensor system, CardioMEMS, received expanded FDA clearance, allowing patients in the earlier stages of heart failure to use the technology.

The system is designed to monitor pressure changes in the heart and is implanted in the patient’s pulmonary artery during minimally invasive surgery.

Abbott in 2021 won FDA clearance for imaging software that uses artificial intelligence to give doctors a clearer view of blood flow and blockages in cardiovascular systems.

The Ultreon 1.0 software combines optical coherence tomography and AI to help doctors determine the next steps in treatment.

Other companies in the glucose monitoring space include Dexcom’s Stelo, a wearable glucose monitoring device that hit the US market in August, which tracks blood glucose levels 24/7 and does not require a prescription.

Medtronic offers two smart continuous glucose monitoring systems: Guardian Connect, which alerts patients to high or low blood glucose levels up to 60 minutes in advance so they can take action, and Guardian Sensor 3, which also predicts high or low blood glucose levels up to an hour in advance and integrates with the company’s latest insulin pump therapy.

The HIMSS Healthcare Cybersecurity Forum is scheduled to take place in Washington, DC from October 31 to November 1. Learn more and register.



Source link

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
admin
  • Website

Related Posts

Community nurses ‘must be central’ in new neighbourhood health service

July 4, 2025

Nurses call for delivery plan to achieve NHS prevention agenda

July 4, 2025

what it means for digital transformation| Nursing Times

July 4, 2025
Leave A Reply Cancel Reply

Top Posts

Community nurses ‘must be central’ in new neighbourhood health service

July 4, 2025

Understand Latin health at Adelantando Healthcare Conference

January 1, 1970

Seton Hall's new university university program explores women's healthcare for future health leaders

January 1, 1970

North Texas medical chain faces possible $300 million fine for 20,000 fake Medicare claims

January 28, 2003
Don't Miss

Community nurses ‘must be central’ in new neighbourhood health service

By adminJuly 4, 2025

Community nurses must play a central role in the development of the government’s plans for…

Nurses call for delivery plan to achieve NHS prevention agenda

July 4, 2025

what it means for digital transformation| Nursing Times

July 4, 2025

Nursing livery company celebrates ‘red-letter day’ for profession

July 4, 2025

Subscribe to Updates

Subscribe to our newsletter and never miss our latest news

Subscribe my Newsletter for New Posts & tips Let's stay updated!

About Us
About Us

Welcome to HomeCareNews.us, your trusted source for comprehensive information on home healthcare services. Our mission is to empower individuals and families by providing accurate, up-to-date, and insightful information about essential home care services in USA.

Facebook X (Twitter) Pinterest YouTube WhatsApp
Our Picks

Community nurses ‘must be central’ in new neighbourhood health service

July 4, 2025

Nurses call for delivery plan to achieve NHS prevention agenda

July 4, 2025

what it means for digital transformation| Nursing Times

July 4, 2025
Most Popular

Community nurses ‘must be central’ in new neighbourhood health service

July 4, 2025

Understand Latin health at Adelantando Healthcare Conference

January 1, 1970

Seton Hall's new university university program explores women's healthcare for future health leaders

January 1, 1970
  • Home
  • About Us
  • Advertise with Us
  • Contact us
  • DMCA Policy
  • Privacy Policy
  • Terms & Conditions
© 2025 HomecareNews.US

Type above and press Enter to search. Press Esc to cancel.